BioSpace News Archive

Business

Ten63 Therapeutics Announces Multi-Target Drug Discovery Collaboration with Boehringer Ingelheim

Ten63 Therapeutics announced today a multi-target drug discovery collaboration with Boehringer Ingelheim.

December 6, 2023
·
2 min read
Pharm Country

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

Century Therapeutics today announced that it will host a conference call and live audio webcast on Monday, December 11 at 7:30 AM PT/ 10:30 AM ET to discuss initial clinical data supporting a multi-dosing strategy from its ongoing first-in-human Phase 1 ELiPSE-1.

December 6, 2023
·
5 min read
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program

Cybin Inc. today announced that the United States Patent and Trademark Office (“USPTO”) has granted U.S. patent 11,834,410 in support of its CYB003 program.

December 6, 2023
·
6 min read
Business

Stryker announces Dr. Srikant Datar will retire from Board of Directors

Stryker (NYSE:SYK) announced today that after 15 years of distinguished service, Dr. Srikant Datar has notified the Company that he will not stand for re-election at Stryker’s 2024 Annual Meeting of Shareholders, which is expected to be held on May 9, 2024.

December 6, 2023
·
2 min read
Drug Development

Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD

Phathom Pharmaceuticals, Inc. announced today the FDA has accepted for review the company’s NDA for VOQUEZNA (vonoprazan) as a daily treatment of heartburn associated with Non-Erosive gastroesophageal reflux disease (GERD) in adults.

December 6, 2023
·
11 min read
Genetown

Jnana Therapeutics to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference

Jnana Therapeutics today announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will participate in a fireside chat at the RBC Capital Markets Healthcare Private Company Virtual Conference on Wednesday, December 13, 2023 at 4:30 p.m. ET.

December 6, 2023
·
1 min read
Bio NC

Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans.

December 6, 2023
·
1 min read
Business

CARGO Therapeutics Announces Scientific Advisory Board

CARGO Therapeutics, Inc. today announced the formation of a Scientific Advisory Board (SAB) comprised of distinguished experts in cancer research, immunology, and CAR T-cell therapy.

December 6, 2023
·
4 min read
Biotech Beach

Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that the American Society of Hematology (ASH) Annual Meeting and Exposition 2023 will feature a broad range of content covering OGM’s utility for research in areas including myeloid cancer, hematological malignancy, leukemia and blood disorders.

December 6, 2023
·
8 min read
Business

Empress Therapeutics Appoints Virginia Finnerty-Brooks Chief Business Officer

Empress Therapeutics today announced that Virginia Finnerty-Brooks has been appointed Chief Business Officer (CBO).

December 6, 2023
·
3 min read